Aerovate Therapeutics shares owned by Octagon Capital Advisors
Quarter-by-quarter ownership of Aerovate Therapeutics (AVTE) shares owned by Octagon Capital Advisors
from 13F filings
Historical chart of Octagon Capital Advisors investment in Aerovate Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aerovate Therapeutics held by Octagon Capital Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aerovate Therapeutics by Octagon Capital Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $9.1M | 404k | 22.63 |
| 2023-09-30 | $6.7M | 497k | 13.57 |
| 2023-06-30 | $11M | 622k | 17.15 |
| 2023-03-31 | $13M | 622k | 20.17 |
| 2022-12-31 | $18M | 622k | 29.30 |